368 related articles for article (PubMed ID: 31788359)
1. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.
Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H
PeerJ; 2019; 7():e8096. PubMed ID: 31788359
[TBL] [Abstract][Full Text] [Related]
2. Identification of key genes involved in the metastasis of clear cell renal cell carcinoma.
Wei W; Lv Y; Gan Z; Zhang Y; Han X; Xu Z
Oncol Lett; 2019 May; 17(5):4321-4328. PubMed ID: 30988807
[TBL] [Abstract][Full Text] [Related]
3. Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis.
Peng L; Cao Z; Wang Q; Fang L; Yan S; Xia D; Wang J; Bi L
Front Oncol; 2022; 12():963483. PubMed ID: 36313709
[TBL] [Abstract][Full Text] [Related]
4. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Deng JL; Xu YH; Wang G
Front Genet; 2019; 10():695. PubMed ID: 31428132
[No Abstract] [Full Text] [Related]
5. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
[TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes associated with bladder cancer using bioinformatic analyses.
Zheng W; Zhao Y; Wang T; Zhao X; Tan Z
Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.
Cui H; Xu L; Li Z; Hou KZ; Che XF; Liu BF; Liu YP; Qu XJ
Oncol Lett; 2020 Aug; 20(2):1573-1584. PubMed ID: 32724399
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
[TBL] [Abstract][Full Text] [Related]
9. Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Qu G; Wang H; Yan H; Liu G; Wu M
Front Oncol; 2022; 12():857619. PubMed ID: 35296026
[TBL] [Abstract][Full Text] [Related]
10. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
Sui Y; Lu K; Fu L
PeerJ; 2021; 9():e11272. PubMed ID: 33976979
[TBL] [Abstract][Full Text] [Related]
11. Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
Xu D; Xu Y; Lv Y; Wu F; Liu Y; Zhu M; Chen D; Bai B
Biomed Res Int; 2020; 2020():2137319. PubMed ID: 32309427
[TBL] [Abstract][Full Text] [Related]
12. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
[TBL] [Abstract][Full Text] [Related]
13. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis.
Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X
Front Physiol; 2018; 9():399. PubMed ID: 29720944
[TBL] [Abstract][Full Text] [Related]
14. The screening of pivotal gene expression signatures and biomarkers in renal carcinoma.
Ruan H; Li S; Tong J; Cao Q; Song Z; Wang K; Huang Y; Bao L; Chen X; Yang H; Chen K; Zhang X
J Cancer; 2019; 10(25):6384-6394. PubMed ID: 31772671
[TBL] [Abstract][Full Text] [Related]
15. Identification of Core Genes Involved in the Metastasis of Clear Cell Renal Cell Carcinoma.
Peng R; Wang Y; Mao L; Fang F; Guan H
Cancer Manag Res; 2020; 12():13437-13449. PubMed ID: 33408516
[TBL] [Abstract][Full Text] [Related]
16. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
17. Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach.
Chen Y; Teng L; Liu W; Cao Y; Ding D; Wang W; Chen H; Li C; An R
Cancer Cell Int; 2016; 16():16. PubMed ID: 26941587
[TBL] [Abstract][Full Text] [Related]
18. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential crucial genes associated with carcinogenesis of clear cell renal cell carcinoma.
Song E; Song W; Ren M; Xing L; Ni W; Li Y; Gong M; Zhao M; Ma X; Zhang X; An R
J Cell Biochem; 2018 Jul; 119(7):5163-5174. PubMed ID: 29227586
[TBL] [Abstract][Full Text] [Related]
20. Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis.
Ni M; Liu X; Wu J; Zhang D; Tian J; Wang T; Liu S; Meng Z; Wang K; Duan X; Zhou W; Zhang X
Front Genet; 2018; 9():469. PubMed ID: 30369945
[No Abstract] [Full Text] [Related]
[Next] [New Search]
